Caffeine
General
- Type: Stimulant, Respiratory Stimulant, Nonselective Phosphodiesterase Enzyme Inhibitor
- Dosage Forms: tablets, capsules, lozenges, oral solution, injectable solution
- Dosage Strengths: tablets: 200 mg; capsules: 200 mg; lozenges: 75 mg; oral solution: 20 mg/mL; injectable solution: 20 mg/mL
- Routes of Administration: PO, IV, IM
- Common Trade Names: NoDoz, Recharge, Vivarin, Diurex, Cafcit
Adult Dosing
Pediatric Dosing
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Pharmacology
- Half-life: 5 hours
- Metabolism: Liver CYP450
- Excretion: Urine
- Mechanism of Action: Adenosine receptor antagonist
See Also
References
- Food Standards Agency (2001) Statement on the Reproductive Effects of Caffeine. London: Food Standards Agency.
- Juliano LM and Griffiths RR. Caffeine. In Lowinson, J.H., Ruiz, P., Millman, R.B., Langrod, J.G. (Eds.). Substance Abuse: A Comprehensive Textbook, Fourth Edition. 2005. PP. 403-421. Baltimore: Lippincott, Williams, & Wilkins.
This article is issued from
Wikem.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.